Pediatric cardiomyopathy - A long way to go

New England Journal of Medicine

Volumn 348, Issue 17, 2003, Pages 1703-1705

  Strauss, Arnold ^a   Lock, James E ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; BECKER MUSCULAR DYSTROPHY; CARDIOMYOPATHY; CHILDHOOD DISEASE; CONGENITAL HEART DISEASE; DUCHENNE MUSCULAR DYSTROPHY; EDITORIAL; FAMILIAL DISEASE; FAMILY HISTORY; GENDER; HEART DISEASE; HEART TRANSPLANTATION; HEREDITY; HUMAN; INCIDENCE; PATHOGENESIS; PRIORITY JOURNAL; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES; WESTERN HEMISPHERE; X CHROMOSOME;

AUSTRALIA; CARDIOMYOPATHIES; CHILD; FEMALE; HUMANS; INCIDENCE; MALE; MUTATION; SEX DISTRIBUTION; UNITED STATES;

EID: 0037464514     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe030027     Document Type: Editorial

References (16)

1. Report of the New England Regional Infant Cardiac Program. Pediatrics 1980;65:375-461.
2. Boneva RS, Botto LD, Moore CA, Yang Q, Correa A, Erickson JD. Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997. Circulation 2001; 103:2376-81.
3. Olson EN, Srivastava D. Molecular pathways controlling heart development. Science 1996;272:671-6.
4. Kumar K, Thatai D, Saxena A, et al. Pediatric dilated cardiomyopathy: prognosis in a developing nation is comparable to developed nations. Int J Cardiol (in press).
5. Lipshultz SE. Ventricular dysfunction clinical research in infants, children and adolescents. Prog Pediatr Cardiol 2000;12:1-28.
6. Bilgic A, Ozbarlas N, Ozkutlu S, Ozer S, Ozme S. Cardiomyopathies in children: clinical, epidemiological and prognostic evaluation. Jpn Heart J 1990;31:789-97.
7. Nugent AW, Daubeney PEF, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med 2003;348: 1639-46.
8. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003;348:1647-55.
9. Arola A, Jokinen E, Ruuskanen O, et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents: a nationwide study in Finland. Am J Epidemiol 1997;146:385-93.
10. Michels VV, Moll PP, Miller FA, et al. The frequency of familial dilated cardiomyopathy in a series ofpadents with idiopathic dilated cardiomyopathy. N Engl J Med 1992;326:77-82.
11. Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med 1994;330:913-9.
12. Schmitt JP, Kamisago M, Asahi M, et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 2003;299:1410-3.
13. Arad M, Benson DW, Perez-Atayde AR, et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. J Clin Invest 2002;109:357-62.
14. Bennett MJ, Rinaldo P, Strauss AW. Inborn errors of mitochondrial fatty acid oxidation. Crit Rev Clin Lab Sci 2000;37:1-44.
15. Strauss AW. Defects of mitochondrial proteins and pediatric heart disease. Prog Pediatr Cardiol 1996;6:83-90.
16. Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafish. Science 2002;298:2188-90.